Logo image of TFFP

TFF Pharmaceuticals Inc (TFFP) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TFFP - US87241J2033 - Common Stock

0.065 USD
-0.1 (-60.05%)
Last: 12/12/2024, 8:00:00 PM
0.135 USD
+0.07 (+107.69%)
After Hours: 12/12/2024, 8:00:00 PM
Fundamental Rating

2

Taking everything into account, TFFP scores 2 out of 10 in our fundamental rating. TFFP was compared to 191 industry peers in the Pharmaceuticals industry. TFFP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TFFP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year TFFP has reported negative net income.
  • TFFP had a negative operating cash flow in the past year.
  • TFFP had negative earnings in each of the past 5 years.
  • In the past 5 years TFFP always reported negative operating cash flow.
TFFP Yearly Net Income VS EBIT VS OCF VS FCFTFFP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

  • TFFP has a worse Return On Assets (-261.68%) than 92.67% of its industry peers.
  • Looking at the Return On Equity, with a value of -590.38%, TFFP is doing worse than 81.68% of the companies in the same industry.
Industry RankSector Rank
ROA -261.68%
ROE -590.38%
ROIC N/A
ROA(3y)-128.2%
ROA(5y)-111.66%
ROE(3y)-147.01%
ROE(5y)-124.69%
ROIC(3y)N/A
ROIC(5y)N/A
TFFP Yearly ROA, ROE, ROICTFFP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 1K 2K 3K

1.3 Margins

  • TFFP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TFFP Yearly Profit, Operating, Gross MarginsTFFP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 -10K -20K -30K

More info and screens

4

2. Health

2.1 Basic Checks

  • TFFP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TFFP has less shares outstanding than it did 1 year ago.
  • TFFP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TFFP Yearly Shares OutstandingTFFP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
TFFP Yearly Total Debt VS Total AssetsTFFP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

  • TFFP has an Altman-Z score of -34.71. This is a bad value and indicates that TFFP is not financially healthy and even has some risk of bankruptcy.
  • TFFP's Altman-Z score of -34.71 is on the low side compared to the rest of the industry. TFFP is outperformed by 91.10% of its industry peers.
  • There is no outstanding debt for TFFP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -34.71
ROIC/WACCN/A
WACC9.6%
TFFP Yearly LT Debt VS Equity VS FCFTFFP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

  • TFFP has a Current Ratio of 0.89. This is a bad value and indicates that TFFP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • TFFP has a worse Current ratio (0.89) than 89.53% of its industry peers.
  • A Quick Ratio of 0.89 indicates that TFFP may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.89, TFFP is not doing good in the industry: 83.25% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.89
TFFP Yearly Current Assets VS Current LiabilitesTFFP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 50.46% over the past year.
  • Looking at the last year, TFFP shows a very strong growth in Revenue. The Revenue has grown by 25.57%.
EPS 1Y (TTM)50.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64%
Revenue 1Y (TTM)25.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-17.71%

3.2 Future

  • TFFP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.17% yearly.
  • The Revenue is expected to grow by 153.49% on average over the next years. This is a very strong growth
EPS Next Y65.1%
EPS Next 2Y30.1%
EPS Next 3Y21.17%
EPS Next 5YN/A
Revenue Next Year60.13%
Revenue Next 2Y5.41%
Revenue Next 3Y153.49%
Revenue Next 5YN/A

3.3 Evolution

TFFP Yearly Revenue VS EstimatesTFFP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
TFFP Yearly EPS VS EstimatesTFFP Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -10 -20 -30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • TFFP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TFFP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TFFP Price Earnings VS Forward Price EarningsTFFP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TFFP Per share dataTFFP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as TFFP's earnings are expected to grow with 21.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.1%
EPS Next 3Y21.17%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for TFFP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TFF Pharmaceuticals Inc

NASDAQ:TFFP (12/12/2024, 8:00:00 PM)

After market: 0.135 +0.07 (+107.69%)

0.065

-0.1 (-60.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-20
Earnings (Next)N/A
Inst Owners22.48%
Inst Owner Change0%
Ins Owners3.36%
Ins Owner Change0%
Market Cap288.60K
Revenue(TTM)1.16M
Net Income(TTM)-18.52M
Analysts82.86
Price Target30.6 (46976.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.8%
Min EPS beat(2)1.96%
Max EPS beat(2)29.64%
EPS beat(4)3
Avg EPS beat(4)8.63%
Min EPS beat(4)-4.11%
Max EPS beat(4)29.64%
EPS beat(8)7
Avg EPS beat(8)20.47%
EPS beat(12)9
Avg EPS beat(12)12.21%
EPS beat(16)10
Avg EPS beat(16)4.34%
Revenue beat(2)1
Avg Revenue beat(2)159.82%
Min Revenue beat(2)-5.2%
Max Revenue beat(2)324.84%
Revenue beat(4)3
Avg Revenue beat(4)124.27%
Min Revenue beat(4)-5.2%
Max Revenue beat(4)324.84%
Revenue beat(8)6
Avg Revenue beat(8)325.23%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)22.34%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)166.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 0.09
P/tB 0.09
EV/EBITDA N/A
EPS(TTM)-6.44
EYN/A
EPS(NY)-3.85
Fwd EYN/A
FCF(TTM)-2.85
FCFYN/A
OCF(TTM)-2.84
OCFYN/A
SpS0.26
BVpS0.71
TBVpS0.71
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -261.68%
ROE -590.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-128.2%
ROA(5y)-111.66%
ROE(3y)-147.01%
ROE(5y)-124.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.89
Quick Ratio 0.89
Altman-Z -34.71
F-Score4
WACC9.6%
ROIC/WACCN/A
Cap/Depr(3y)402.4%
Cap/Depr(5y)N/A
Cap/Sales(3y)429.86%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64%
EPS Next Y65.1%
EPS Next 2Y30.1%
EPS Next 3Y21.17%
EPS Next 5YN/A
Revenue 1Y (TTM)25.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-17.71%
Revenue Next Year60.13%
Revenue Next 2Y5.41%
Revenue Next 3Y153.49%
Revenue Next 5YN/A
EBIT growth 1Y21.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year209.69%
EBIT Next 3Y45.36%
EBIT Next 5YN/A
FCF growth 1Y60.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.76%
OCF growth 3YN/A
OCF growth 5YN/A

TFF Pharmaceuticals Inc / TFFP FAQ

What is the fundamental rating for TFFP stock?

ChartMill assigns a fundamental rating of 3 / 10 to TFFP.


What is the valuation status for TFFP stock?

ChartMill assigns a valuation rating of 1 / 10 to TFF Pharmaceuticals Inc (TFFP). This can be considered as Overvalued.


What is the profitability of TFFP stock?

TFF Pharmaceuticals Inc (TFFP) has a profitability rating of 0 / 10.


How financially healthy is TFF Pharmaceuticals Inc?

The financial health rating of TFF Pharmaceuticals Inc (TFFP) is 5 / 10.